Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
This systemic reach makes the BPC-157 TB-500 blend particularly relevant for research involving diffuse or multi-site tissue damage
Future: Dedicated NASH Phase 3 Trial Expected Timeline IF Retatrutide Approved for Obesity/Diabetes (2028): 2027-2028: Dedicated NASH Phase 3 trial begins Population: Biopsy-confirmed NASH with fibrosis (F1-F3) Primary endpoint: NASH resolution without worsening fibrosis Baseline and Week 72-96 liver biopsies Duration: 18-24 months minimum 2029-2030: Trial results published 2030-2031: FDA approval decision for NASH indication Why This Matters Current Reality: Only one FDA-approved medication exists for NASH resmetirom (Rezdiffra), approved March 2024
Strengths and limitations of study This study has several strengths
You can buy Retatrutide in Australia directly from Aussie Peptide Store
Why Our Melanotan 2 Does Not Include Syringes When you buy from TruTan, youll see that Melanotan 2 does not come with syringes in your box
